Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0NW2B
|
||||
Former ID |
DIB010242
|
||||
Drug Name |
NK3 antagonist PET ligand
|
||||
Synonyms |
NK3 antagonist PET ligand (psychiatric disease); NK3 antagonist PET ligand (psychiatric disease), AstraZeneca
|
||||
Indication | Psychiatric disorder [ICD9: 290-319; ICD10:F01-F99] | Investigative | [543793] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
c1ccc2c(c1)c(c(c(n2)c1ccccc1)[S@@](=O)C)C(=O)N[C@H](c1c<br />cccc1)CC
|
||||
Target and Pathway | |||||
Target(s) | Nigral tachykinin NK(3) receptor | Target Info | Antagonist | [543793] | |
Reactome | G alpha (q) signalling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.